Skip to content

Category Archives: El-Hibri


  1. Emergent BioSolutions to Release Fourth Quarter and Full Year 2011 Financial Results and Conduct a Conference Call on March 8, 2012 February 2, 2012

    Posted in Chief executive officer, Chief financial officer, El-Hibri, Emergent BioSolutions, Fuad El-Hibri, Shareholders.

    No comments
  2. Emergent Announces Initiation of a Phase 1b/2 Study of TRU-016 in Combination with Rituximab and Bendamustine in Subjects with Relapsed – Indolent Lymphoma August 24, 2011

    Posted in Chief Medical Officer, Chief executive officer, El-Hibri, Emergent BioSolutions, Fuad El-Hibri, Healthcare, Lymphoma.

    No comments
  3. Emergent BioSolutions to Present at Jefferies 2011 Global Healthcare Conference June 1, 2011

    Posted in Business, El-Hibri, Financial Performance, Fuad El-Hibri, Healthcare Conference, Investors.

    No comments
  4. Emergent BioSolutions to Present Today at Needham & Company Healthcare Conference April 5, 2011

    Posted in Chief executive officer, El-Hibri, Emergent BioSolutions, Fuad Elhibri, Healthcare Conference.

    No comments
  5. Emergent BioSolutions to Release Fourth Quarter and Full Year 2010 Financial Results and Conduct a Conference Call on March 10 February 25, 2011

    Posted in Biotechnology and Pharmaceuticals, Chief executive officer, El-Hibri, Emergent BioSolutions, Fuad El-Hibri.

    No comments
  6. CEO took roundabout path to Emergent January 7, 2011

    Posted in Business, Chief executive officer, El-Hibri, Emergent BioSolutions, Entrepreneur, Food and Drug Administration, Fuad El-Hibri, Trubion Pharmaceuticals, United States, United States Department of Health and Human Services, Vaccine, Yale University, biotechnology.

    No comments
  7. Fuad El-Hibri Recognized by Vilcek Foundation December 10, 2010

    Posted in Chief executive officer, El-Hibri, El-Hibri Fuad, El-Hibri Peace Education Prize, Emergent BioSolutions, Fuad El-Hibri, Peace Education.

    No comments
  8. Fuad El-Hibri and the International Biomedical Research Alliance November 13, 2010

    Posted in BioThrax, Chief executive officer, El-Hibri, Emergent BioSolutions, Food and Drug Administration, Fuad El-Hibri, United States.

    No comments
  9. Emergent BioSolutions reacts to BARDA’s Request for Proposal cancellation December 11, 2009

    Posted in Chief executive officer, El-Hibri, El-Hibri Fuad, Emergent BioSolutions, Emergent BioSystems, Fuad Elhibri, biotechnology, technology.

    No comments
  10. October 9, 2008 - Farr Honors Former Santa Cruz Mayor October 17, 2009

    Posted in El-Hibri, Foundation, Peace Education, Resource Center, Washington, colleagues.

    No comments
    11. DeliciousDiggFacebook
    RSS FeedStumbleUponTwitter